Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aims: Radiotherapy is an essential component of cancer treatment, requiring accurate dose planning to optimise tumour control while sparing healthy tissues. This study, originating from a radiobiology workshop held during the 27th Congrès National de Cancérologie et de Radiothérapie-2024 in Sousse, Tunisia, aims to investigate advanced dose modelling approaches, focussing on the linear-quadratic (LQ) and linear-quadratic-linear (LQL) models, to refine the calculation of biologically effective doses (BED) and improve treatment personalisation.

Methods: The workshop brought together experts in the field to discuss and evaluate the latest advancements in dose modelling, providing a comprehensive overview of current best practices and emerging trends. Using tools such as LQL-equiv and other BED calculators, we integrated patient-specific data (eg, fractionation schedules and organ-at-risk (OAR) constraints) to predict outcomes such as normal tissue complication probabilities (NTCPs). Unlike many theoretical studies, our approach embeds these models within a unified interface tailored to real clinical scenarios, enabling practitioners to simulate and adjust treatment plans based on complex, practical constraints.

Results: Through a series of clinical case studies (including treatment interruptions, palliative boosts, and re-irradiation scenarios), participant responses were analysed using the Jaccard similarity index, revealing a significant lack of consensus in treatment planning decisions (mean agreement of 25.83%). This variation illustrates the current ambiguity among clinicians regarding which model to use and how to apply it, despite access to advanced tools. This heterogeneity in decision-making could lead to divergent treatment recommendations for patients with clinically similar profiles.

Conclusion: While the LQ and LQL models offer promising tools for personalised radiotherapy, their interpretation and implementation remain highly variable. In addition, the question of professional responsibility in dose equivalence calculations emerged as a key issue as many departments lack clearly defined accountability frameworks. This study emphasises the need for standardised guidelines, enhanced training programs, and decision support systems to reduce interobserver variability and ensure effective clinical adoption, ultimately improving patient care. The findings underscore the importance of harmonising predictive modelling practices to achieve more consistent and effective radiotherapy outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clon.2025.103893DOI Listing

Publication Analysis

Top Keywords

linear-quadratic linear-quadratic-linear
8
linear-quadratic-linear lql
8
dose modelling
8
lql models
8
treatment
6
dose
5
improving clinical
4
clinical decision-making
4
radiotherapy
4
decision-making radiotherapy
4

Similar Publications

Aims: Radiotherapy is an essential component of cancer treatment, requiring accurate dose planning to optimise tumour control while sparing healthy tissues. This study, originating from a radiobiology workshop held during the 27th Congrès National de Cancérologie et de Radiothérapie-2024 in Sousse, Tunisia, aims to investigate advanced dose modelling approaches, focussing on the linear-quadratic (LQ) and linear-quadratic-linear (LQL) models, to refine the calculation of biologically effective doses (BED) and improve treatment personalisation.

Methods: The workshop brought together experts in the field to discuss and evaluate the latest advancements in dose modelling, providing a comprehensive overview of current best practices and emerging trends.

View Article and Find Full Text PDF

Radiobiological Meta-Analysis of the Response of Prostate Cancer to High-Dose-Rate Brachytherapy: Investigation of the Reduction in Control for Extreme Hypofractionation.

Cancers (Basel)

April 2025

Group of Medical Physics and Biomathematics, Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain.

Background/objectives: Clinical studies have shown a marked reduction in tumor control in prostate cancer treated with radically hypofractionated high-dose-rate brachytherapy (HDR-BT). The purpose of this study was to analyze the dose-response of prostate cancer treated with HDR-BT, specifically aiming at investigating the potential failure of the linear-quadratic (LQ) model to describe the response at large doses-per-fraction.

Methods: We collated a dataset of dose-response to HDR-BT (3239 patients).

View Article and Find Full Text PDF

Purpose: To develop and compare normal tissue complication probability (NTCP) models for recurrent brain metastases (BMs) treated with repeat single-fraction stereotactic radiosurgery (SRS), considering time-dependent discounted prior dose.

Methods And Materials: We developed three NTCP models (M0, M1-retreat, and M1-combo models) of BMs treated with GammaKnife-based SRS. The maximum dose is 0.

View Article and Find Full Text PDF

Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation.

Radiother Oncol

January 2024

Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin, China. Electronic address: zyuan@tmu

Article Synopsis
  • The study focuses on the importance of accurately contouring the brachial plexus (BP) to assess toxicity and identify metrics for predicting radiation-induced brachial plexopathy (RIBP) after targeted radiotherapy.
  • Patients with a specific planning target volume (PTV) close to the BP were analyzed, using established radiation therapy atlases for contouring.
  • Results showed that maximum doses to the BP were linked to a significant risk of RIBP, highlighting that relying on subclavian-axillary veins for dosimetry may underestimate risk, especially in certain patient groups.
View Article and Find Full Text PDF

Different radiation therapy (RT) strategies, e.g. conventional fractionation RT (CFRT), hypofractionation RT (HFRT), stereotactic body RT (SBRT), adaptive RT, and re-irradiation are often used to treat head and neck (HN) cancers.

View Article and Find Full Text PDF